CLINICAL_TRIALS
research
· 2026-04-23
Clinical Trial Update: Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure [NA]
Summary
Recruitment is underway for a Barostim-enabled neurohormonal intervention intended to improve treatment of heart failure. The conditions include heart failure w…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: CVRx, Inc. | Conditions: Heart Failure, Heart Failure NYHA Class II | NA | Status: RECRUITING